Organogenesis Holdings INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Soleus Capital Master Fund and its affiliates reported a beneficial ownership of 7.9% in Organogenesis Holdings Inc., holding 9,985,951 shares as of December 31, 2025.
NASDAQ
First Light Asset Management and Mathew P. Arens report increased beneficial ownership in Organogenesis Holdings, Inc., now holding 6.55% of common stock.
NASDAQ
Soleus Capital Master Fund, L.P. and its affiliated entities, including Guy Levy, have reported a collective beneficial ownership of 9.9% in Organogenesis Holdings Inc., totaling 12,484,876 shares.